These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38171343)

  • 1. Mechanistic Links between Central Obesity and Cardiorenal Metabolic Diseases.
    Al-Chalabi S; Syed AA; Kalra PA; Sinha S
    Cardiorenal Med; 2024; 14(1):12-22. PubMed ID: 38171343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance.
    Aroor AR; McKarns S; Demarco VG; Jia G; Sowers JR
    Metabolism; 2013 Nov; 62(11):1543-52. PubMed ID: 23932846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Range of adiposity and cardiorenal syndrome.
    Pazos F
    World J Diabetes; 2020 Aug; 11(8):322-350. PubMed ID: 32864046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity, kidney dysfunction, and inflammation: interactions in hypertension.
    Hall JE; Mouton AJ; da Silva AA; Omoto ACM; Wang Z; Li X; do Carmo JM
    Cardiovasc Res; 2021 Jul; 117(8):1859-1876. PubMed ID: 33258945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity Treatments to Improve Type 1 Diabetes (OTID): a randomized controlled trial of the combination of glucagon-like peptide 1 analogues and sodium-glucose cotransporter 2 inhibitors-protocol for Obesity Treatments to Improve Type 1 Diabetes (the OTID trial).
    Al-Ozairi E; Narula K; Miras AD; Taghadom E; Samad AE; Al Kandari J; Alyosef A; Mashankar A; Al-Najim W; le Roux CW
    Trials; 2024 Feb; 25(1):129. PubMed ID: 38365744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Renin Angiotensin Aldosterone System in Obesity and Hypertension: Roles in the Cardiorenal Metabolic Syndrome.
    Cabandugama PK; Gardner MJ; Sowers JR
    Med Clin North Am; 2017 Jan; 101(1):129-137. PubMed ID: 27884224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity-Related Glomerulopathy: Clinical Management.
    Herman-Edelstein M; Weinstein T; Chagnac A
    Semin Nephrol; 2021 Jul; 41(4):358-370. PubMed ID: 34715965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality and Renal Outcomes Are Impacted by Obesity in Cardiorenal Metabolic Disease but Not in People with Concomitant Diabetes Mellitus.
    Al-Chalabi S; Chinnadurai R; Kalra PA; Sinha S
    Cardiorenal Med; 2024; 14(1):23-33. PubMed ID: 38160668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms.
    Hall JE; do Carmo JM; da Silva AA; Wang Z; Hall ME
    Circ Res; 2015 Mar; 116(6):991-1006. PubMed ID: 25767285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAAS inhibition and cardiorenal syndrome.
    Onuigbo MA
    Curr Hypertens Rev; 2014; 10(2):107-11. PubMed ID: 25549841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sodium-glucose cotransporter-2 inhibitors and aldosterone antagonists, in addition to renin-angiotensin system antagonists, on major adverse kidney outcomes in patients with type 2 diabetes and chronic kidney disease: A systematic review and network meta-analysis.
    Yang S; Zhao L; Mi Y; He W
    Diabetes Obes Metab; 2022 Nov; 24(11):2159-2168. PubMed ID: 35712807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of metabolic syndrome and chronic kidney disease.
    Scurt FG; Ganz MJ; Herzog C; Bose K; Mertens PR; Chatzikyrkou C
    Obes Rev; 2024 Jan; 25(1):e13649. PubMed ID: 37783465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity, kidney dysfunction and hypertension: mechanistic links.
    Hall JE; do Carmo JM; da Silva AA; Wang Z; Hall ME
    Nat Rev Nephrol; 2019 Jun; 15(6):367-385. PubMed ID: 31015582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA.
    Mark PB; Sarafidis P; Ekart R; Ferro CJ; Balafa O; Fernandez-Fernandez B; Herrington WG; Rossignol P; Del Vecchio L; Valdivielso JM; Mallamaci F; Ortiz A; Nistor I; Cozzolino M
    Nephrol Dial Transplant; 2023 Oct; 38(11):2444-2455. PubMed ID: 37230946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in Adults.
    Mancini GBJ; O'Meara E; Zieroth S; Bernier M; Cheng AYY; Cherney DZI; Connelly KA; Ezekowitz J; Goldenberg RM; Leiter LA; Nesrallah G; Paty BW; Piché ME; Senior P; Sharma A; Verma S; Woo V; Darras P; Grégoire J; Lonn E; Stone JA; Yale JF; Yeung C; Zimmerman D
    Can J Cardiol; 2022 Aug; 38(8):1153-1167. PubMed ID: 35961754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiorenal Syndrome Revisited.
    Zannad F; Rossignol P
    Circulation; 2018 Aug; 138(9):929-944. PubMed ID: 30354446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of dietary fiber intake on glycemic control, cardiovascular risk factors and chronic kidney disease in Japanese patients with type 2 diabetes mellitus: the Fukuoka Diabetes Registry.
    Fujii H; Iwase M; Ohkuma T; Ogata-Kaizu S; Ide H; Kikuchi Y; Idewaki Y; Joudai T; Hirakawa Y; Uchida K; Sasaki S; Nakamura U; Kitazono T
    Nutr J; 2013 Dec; 12():159. PubMed ID: 24330576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Underuse of cardiorenal protective agents in high-risk diabetes patients in primary care: a cross-sectional study.
    Hao R; Myroniuk T; McGuckin T; Manca D; Campbell-Scherer D; Lau D; Yeung RO
    BMC Prim Care; 2022 May; 23(1):124. PubMed ID: 35606699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paving a Path to Equity in Cardiorenal Care.
    Mohottige D
    Semin Nephrol; 2024 Mar; 44(2):151519. PubMed ID: 38960842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DPP-4 Inhibitors as Therapeutic Modulators of Immune Cell Function and Associated Cardiovascular and Renal Insulin Resistance in Obesity and Diabetes.
    Aroor A; McKarns S; Nistala R; DeMarco V; Gardner M; Garcia-Touza M; Whaley-Connell A; Sowers JR
    Cardiorenal Med; 2013 Apr; 3(1):48-56. PubMed ID: 23946724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.